Bank of Montreal
DNA icon

Bank of Montreal’s Ginkgo Bioworks DNA Stock Holding History

Bank of Montreal’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-308
Closed -$21.9K – 3963
2023
Q4 		$21.9K Sell
308
-779
-72% -$47.7K ﹤0.01% 3713
2023
Q3 		$83.9K Buy
1,087
+112
+11% +$8.95K ﹤0.01% 3324
2023
Q2 		$74.8K Buy
975
+627
+180% +$37.1K ﹤0.01% 3516
2023
Q1 		$18.8K Sell
348
-676
-66% -$42.8K ﹤0.01% 3543
2022
Q4 		$69.6K Sell
1,024
-36
-3% -$3.31K ﹤0.01% 3457
2022
Q3 		$134 Buy
1,060
+387
+58% +$46.1K ﹤0.01% 3361
2022
Q2 		$73 Buy
673
+377
+127% +$46K ﹤0.01% 3530
2022
Q1 		$50K Sell
296
-299
-50% -$58.2K ﹤0.01% 3793
2021
Q4 		$214K Buy
+595
New +$283K ﹤0.01% 2935

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Montreal's DNA Position: Q1 2024 in Review

Bank of Montreal sold out of Ginkgo Bioworks (DNA) in Q1 2024, closing a stake of 308 shares — an estimated $21.9K sold.

Bank of Montreal first reported a position in DNA in Q4 2021 and held it in 9 quarters. The position peaked at $214K in Q4 2021. 342 funds tracked by Wall St. Rank hold DNA as of Q1 2024.

  • Bank of Montreal reported no remaining Ginkgo Bioworks position as of Q1 2024 after selling out during the quarter.
  • Bank of Montreal sold 308 Ginkgo Bioworks shares in Q1 2024, an estimated $21.9K.
  • Bank of Montreal first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 9 quarters.
  • Bank of Montreal's Ginkgo Bioworks position peaked at $214K in Q4 2021.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.